Monograph Details
|
|
Immune System
> Immunization
|
|
YF-VAX |
| Manufacturer |
|
Sanofi Pasteur, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Yellow fever vaccine. |
| Generic Name |
|
Yellow fever vaccine live; for SC inj; contains sorbitol, gelatin; preservative-free;. |
| Indications |
|
Yellow fever immunization. |
| Adults and Children |
|
Give at least 10 days before expected exposure; may repeat every 10yrs. <9 months: not recommended. ≥9 months: 0.5mL SC. |
| Contraindications |
|
Infants <9 months of age. Severe egg allergy (consider skin test and desensitization; see literature). Immunodeficiency or risk of immunosuppression (eg, systemic corticosteroid therapy, chemotherapy, radiation). Thymic dysfunction. |
| Precautions |
|
Latex allergy. Have epinephrine (1:1000) available. Elderly (increased risk of systemic events; evaluate prior to, and monitor for at least 10 days after, vaccination). Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Concomitant vaccines: see literature. |
| Adverse Reactions |
|
Injection site reactions, rash, headache, malaise, myalgia, fever; rare neurotropic or viscerotropic disease. |
| How Supplied |
|
Available only to Yellow Fever Vaccination Centers. |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
